Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629) |
---|
05/20/1999 | WO1999024554A2 Isolation, characterization, and identification of dendritic like cells and methods of using same |
05/20/1999 | WO1999024473A1 Antibodies against phosphorylated vasp (vasodilator-stimulated phosphoprotein), hybridoma cells for their preparation, and their use |
05/20/1999 | WO1999024472A2 Glycosylated antibodies and antibody fragments having reactive ketone groups |
05/20/1999 | WO1999024470A1 Mammalian milk growth factor |
05/20/1999 | WO1999024469A1 Secreted proteins and polynucleotides encoding them |
05/20/1999 | WO1999024457A1 Dna regulatory element for the expression of transgenes in neurons of the mouse forebrain |
05/20/1999 | WO1999024455A1 Detection systems for registering protein interactions and functional relationships |
05/20/1999 | WO1999024078A1 Prevention of immunoreactivity by depleting or inhibiting antigen presenting cells |
05/20/1999 | WO1999024068A1 Immortal avian cell line to grow avian and animal viruses to produce vaccines |
05/20/1999 | WO1999024066A2 Methods and compositions for enhancing immune response and for the production of in vitro mabs |
05/20/1999 | WO1999024058A2 Neuronal uses of bmp-11 |
05/20/1999 | WO1999024057A2 Neuronal uses of bmp-11 |
05/20/1999 | WO1999024045A1 Methods for treatment of tumors and tumor cells using ex vivo activated t cells |
05/20/1999 | WO1999023867A2 Bmog, a protein member of the myelin-oligodendrocyte glycoprotein family and its use |
05/20/1999 | WO1999016890A3 Production of proteins in plant seeds |
05/20/1999 | WO1999016880A3 Protein involved in abscisic acid signalling |
05/20/1999 | WO1999016871A3 Nucleic acid catalysts with endonuclease activity |
05/20/1999 | WO1999015653A3 Tie ligand homologues |
05/20/1999 | WO1999015553A3 Costimulating t-cell polypeptide, monoclonal antibodies, their preparation and use |
05/20/1999 | WO1999010505A3 Production of proteins in eggs |
05/20/1999 | WO1999010494A3 Agonist antibodies to the thrombopoietin receptor, and their therapeutic uses |
05/20/1999 | WO1999010368A9 Presenilin-1 gene promoter |
05/20/1999 | WO1999009182A3 Rab proteins |
05/20/1999 | WO1999007736A3 Lipoprotein-regulating medicaments |
05/20/1999 | WO1999006557A3 Mammalian cell membrane proteins; related reagents |
05/20/1999 | WO1998031796A8 Novel ifn receptor 1 binding proteins, dna encoding them, and methods of modulating cellular response to interferons |
05/20/1999 | CA2310213A1 Novel reovirus-derived proteins, nucleic acids encoding same, and uses therefor |
05/20/1999 | CA2309640A1 Nuclear targeting by means of bacterial proteins |
05/20/1999 | CA2309559A1 Hp90: host membrane receptor for pathogenic bacteria, encoded by the bacterial tir gene |
05/20/1999 | CA2309543A1 Methods and compositions for peptide libraries displayed on light-emitting scaffolds |
05/20/1999 | CA2309538A1 Neuronal uses of bone morphogenetic protein -11 |
05/20/1999 | CA2309535A1 The translation enhancer element of the human amyloid precursor protein gene |
05/20/1999 | CA2309389A1 Dna regulatory element for the expression of transgenes in neurons of the mouse forebrain |
05/20/1999 | CA2309383A1 Genes with restricted expression in mesencephalic dopaminergic neurons |
05/20/1999 | CA2309360A1 Differentially expressed genes in cardiac hypertrophy and their uses in treatment and diagnosis |
05/20/1999 | CA2309346A1 Dull1 coding for a starch synthase and uses thereof |
05/20/1999 | CA2309323A1 Gene coding for thanatin, vector containing same and resulting transformed disease-resistant plants |
05/20/1999 | CA2309322A1 Mutated hydroxy-phenyl pyruvate dioxygenase, dna sequence and method for obtaining herbicide-tolerant plants containing such gene |
05/20/1999 | CA2309320A1 Glycosylated antibodies and antibody fragments having reactive ketone groups |
05/20/1999 | CA2309318A1 Chimeric hydroxy-phenyl pyruvate dioxygenase, dna sequence and method for obtaining plants containing such a gene, with herbicide tolerance |
05/20/1999 | CA2309317A1 Bovine milk growth factor |
05/20/1999 | CA2309207A1 Method of increasing efficiency of directed evolution of a gene using phagemid |
05/20/1999 | CA2309206A1 Methods for treatment of tumors and tumor cells using ex vivo activated t cells |
05/20/1999 | CA2309007A1 Secreted proteins and polynucleotides encoding them |
05/20/1999 | CA2308768A1 125 human secreted proteins |
05/20/1999 | CA2308440A1 Bmog, a protein member of the myelin-oligodendrocyte glycoprotein family and its use |
05/20/1999 | CA2276250A1 Ciita-interacting proteins and methods of use therefor |
05/19/1999 | EP0916726A1 Attaching substances to micro-organisms |
05/19/1999 | EP0915985A1 Improved process for the production of alcoholic beverages using maltseed |
05/19/1999 | EP0915984A1 Production of apomictic seed |
05/19/1999 | EP0915974A1 Modified tie-2-receptor ligands |
05/19/1999 | EP0915973A1 Gene involved in cadasil, method of diagnosis and therapeutic application |
05/19/1999 | EP0915971A2 Polynucleotides from human adult pbmc endocing secreted proteins |
05/19/1999 | EP0915970A1 Type c lectins |
05/19/1999 | EP0915969A1 Method for preventing hiv-1 infection of cd4+ cells |
05/19/1999 | EP0915968A1 Isolation, propagation, and directed differentiation of stem cells from central nervous system of mammals |
05/19/1999 | EP0915967A1 Engineering oral tissues |
05/19/1999 | EP0915966A1 Method for reducing expression variability of transgenes in plant cells |
05/19/1999 | EP0915904A1 Mammalian sex comb on midleg (mammalian scm) acts as a tumor suppressor |
05/19/1999 | EP0915902A1 Transgenic animals expressing artificial epitope-tagged proteins |
05/19/1999 | EP0915648A1 Methods and compositions for the selective modification of nucleic acids |
05/19/1999 | EP0787179A4 INTERLEUKIN-1-g(b) DEFICIENT TRANSGENIC ANIMALS |
05/19/1999 | EP0605627B1 Immunoassay for identifying alcoholics and monitoring alcohol consumption |
05/19/1999 | EP0552257B1 A plant protein useful for treating tumors and hiv infection |
05/19/1999 | EP0434747B1 RECOMBINANT VACCINES BASED ON THE gB-PROTEIN OF MAREK'S DISEASE VIRUS |
05/19/1999 | CN1217024A Chemokine alpha 2 |
05/19/1999 | CN1217023A Canine OB protein compositions and method for recombinant prodn. |
05/19/1999 | CN1217022A Therapeutic uses of keratinocyte growth factor |
05/19/1999 | CN1216994A Apoptosis inducing molecule II |
05/19/1999 | CN1216918A Prevention of leakage during thermotropic phase transition in liposomes and biological cells |
05/18/1999 | US5905187 Antimicrobial peptides and plant disease resistance based thereon |
05/18/1999 | US5905145 These tumor rejection antigen precursors are referred to as ?tage? tumor rejection antigen precursors. |
05/18/1999 | US5905042 Cultured inner cell mass cell lines derived from bovine or porcine embryos |
05/18/1999 | US5905041 Process for preparing and cultivating hematopoietic progenitor cells |
05/18/1999 | US5904920 Regulation of systemic immune responses utilizing cytokines and antigens |
05/18/1999 | US5904716 Method for reconstituting cartilage tissue using demineralized bone and product thereof |
05/18/1999 | CA1340548C Method for producing native hiv gp160 |
05/18/1999 | CA1340544C Human tissue factor related dna segments, polypeptides and antibodies |
05/17/1999 | CA2238669A1 A new transcriptional regulatory factor |
05/14/1999 | WO1999023471A1 Device and method for the separation of human or animal cells of different densities from cellular dispersions which contain them |
05/14/1999 | WO1999023239A1 Efficient construction of gene targeting vectors |
05/14/1999 | WO1999023236A1 Method of dna shuffling |
05/14/1999 | WO1999023231A2 Modification of the tocopherol content of transgenic plants |
05/14/1999 | WO1999023230A1 Reagents and methods useful for detecting diseases of the breast |
05/14/1999 | WO1999023228A1 Svph1-26 dna and polypeptides |
05/14/1999 | WO1999023220A1 Suppressor of cytokine signaling |
05/14/1999 | WO1999023216A2 Hyperthermic inducible expression vectors for gene therapy and methods of use thereof |
05/14/1999 | WO1999023212A1 Novel streptococcal ers |
05/14/1999 | WO1999023208A2 RIBOZYMES TARGETED TO IL-15 mRNA |
05/14/1999 | WO1999023206A1 A method of improved mixing of a varicella-infected cell culture in roller bottles |
05/14/1999 | WO1999023205A1 Hematopoietic stem cells |
05/14/1999 | WO1999023204A1 A method of improved mixing in roller bottles |
05/14/1999 | WO1999023201A1 MURD PROTEIN AND GENE OF $i(STREPTOCOCCUS PYOGENES) |
05/14/1999 | WO1999023106A1 Caspase-14 polypeptides |
05/14/1999 | WO1999022747A1 Bonding of cartilaginous matrices using isolated chondrocytes |
05/14/1999 | WO1999007835A3 1-alpha-hydroxylase |
05/14/1999 | WO1999007739A3 Dna encoding the human synapsin iii gene and uses thereof |
05/14/1999 | WO1999006068A3 Recombinant dimeric envelope vaccine against flaviviral infection |
05/14/1999 | WO1998052582A9 Non-myeloablative tolerogenic treatment |
05/14/1999 | WO1998047917A9 A PURIFIED 20 kDa PRESENILIN 2 C-TERMINAL FRAGMENT AND METHODS OF SCREENING FOR COMPOUNDS THAT INHIBIT PROTEOLYSIS OF PRESENILIN 2 |